Plain-English Summary
Cognitive effects appear possible but uneven across domains and populations. This source helps prevent the overclaim that creatine is a proven general nootropic for everyone.
VV Study Evidence Matrix v1.0
VV Evidence Utility Score
A bounded score for how useful this study is in public explanation, based on evidence tier, design, applicability, endpoint relevance, limitations, safety signals, and publication/source strength.
76/100
Useful Public Evidence
- Evidence tier
- 78/100, weight 18%
- Design strength
- 83/100, weight 18%
- Applicability
- 70/100, weight 16%
- Endpoint relevance
- 88/100, weight 16%
- Limitations transparency
- 60/100, weight 12%
- Safety signal usefulness
- 57/100, weight 10%
- Publication/source strength
- 88/100, weight 10%
Useful for context, but limited by safety signal usefulness, limitations transparency, applicability.
How the study framework works ->Key Findings
- Cognitive effects appear possible but uneven across domains and populations.
- This source helps prevent the overclaim that creatine is a proven general nootropic for everyone.
Limitations
- Mixed outcomes across cognitive domains.
- Trial sizes and dosing protocols vary.
Why It Matters
This record anchors the creatine-brain-muscle-longevity-claims Signal to an exact source URL, study design, population, and endpoint.
Viral Vitalism Verdict
Useful evidence when kept inside its population, endpoint, and design limits.
Sources
- Creatine supplementation and cognitive function systematic review - Experimental Gerontology
Signal cards
Used in signals
Signal coverage connected to this study through explicit study links, canonical source refs, or evidence visualizations.
Creatine Beyond Muscle: Cheap Supplement or Overextended Brain Hack?
Creatine is one of the rare supplements where the baseline evidence is not flimsy. That makes the overclaim risk more interesting: strong sports-nutrition evidence is now being stretched into cognition, depression, aging, women’s health, sleep deprivation, and neuroprotection.
VV Signal Score
78
Promising signal
- Sources
- 7
- Studies
- 6
- Claims
- 4
Claim ledger
Relevant claims
Claim ledger records connected through this study's ID, topic tags, or source IDs.
cannabis: Cannabis brain and cognition risk depends heavily on age,
Cannabis brain and cognition risk depends heavily on age, frequency, potency, recency, route, dependence, vulnerability, and co-use.
cannabis: Cannabis brain-volume evidence varies by population, exposure pattern, age
Cannabis brain-volume evidence varies by population, exposure pattern, age at first use, co-use, measurement method, and confounding.
cannabis: The broad claim that cannabis shrinks your brain overstates
The broad claim that cannabis shrinks your brain overstates a mixed evidence base and swaps endpoints such as perfusion, activation, volume, and cognition.
cannabis: Older-adult cannabis brain-volume counter-signals break the simple shrinkage meme
Older-adult cannabis brain-volume counter-signals break the simple shrinkage meme but do not prove cannabis protects the aging brain.